-Business Standard To make medicines cheaper, in another measure, govt added 200 drug formulations to NLEM list New Delhi/ Mumbai: Pharma companies may soon start wooing chemists as the Narendra Modi government plans to make it mandatory for doctors to prescribe pure-generic drugs, instead of branded generics as they do now. Though the plan was first announced in this year’s Budget, the prime minister spoke about it for the first time at a...
More »SEARCH RESULT
Total Matching Records found : 88
Validation of India's drug patent policy -Latha Jishnu
-Down to Earth A high level UN panel on Access to Medicines wants members to make full use of TRIPS flexibilities to protect public health If ever India needed a clear endorsement of its laws on intellectual property rights (IPRs) and their application in meeting public health priorities, it has come from the highest quarters. The report of the UN Secretary General’s High Level Panel (HLP) on Access to Medicines has, directly...
More »Indian generics bringing down global price of hepatitis C drugs, finds WHO -Himani Chandna
-Hindustan Times India’s generic drug manufacturers have flooded the market with cheaper medicines to treat hepatitis C after Gilead Sciences Inc’s patent application was rejected in January 2015. Thanks to domestic drugmakers, the world is looking to India to reduce the price of hepatitis C drug further. “By scaling up the production of generic medicines, India is playing a pivotal role globally in reducing the prices of medicines for hepatitis C,” said Henk...
More »Intellectual Property Rights policy may hinder drug access -Vidya Krishnan and Puja Mehra
-The Hindu The policy fails to acknowledge that IP is a market-driven model’ India’s National Intellectual Property Rights (IPR) policy, unveiled on Friday, could pose a “serious” hurdle to allowing access to affordable drugs and the South Asian nation missed a chance to put in place a progressive policy, according to experts. The policy left the country’s patent laws intact and specifically did not open up Section 3(d) of the Patents Act, which...
More »Why India needs to show some spine -Leena Menghaney
-The Hindu In the area of intellectual property, public health and access to medicines, the Narendra Modi government should consider its independence to be of the utmost importance. Strong government leadership as well as flexible intellectual property systems are needed in order to effectively combat drug-resistant tuberculosis (DR-TB) and HIV and also antimicrobial resistance and non-communicable diseases. This is true not only for India but also countries which rely on affordable generic...
More »
